Mercado de biotecnología en Europa, por tipo de producto (instrumentos, reactivos y servicios y software), tecnología ( nanobiotecnología , tecnología PCR , secuenciación de ADN , cromatografía , ingeniería y regeneración de tejidos, ensayos basados en células , fermentación y otros), aplicación (biofarmacia, bioindustrial, bioservicios, bioinformática y bioagricultura), usuario final (empresas farmacéuticas y de biotecnología, organizaciones de investigación por contrato, institutos académicos y de investigación y otros), canal de distribución (licitación directa, distribuidores externos y otros), país (Alemania, Italia, Reino Unido, Francia, España, Países Bajos, Bélgica, Suiza, Turquía, Rusia, resto de Europa), tendencias de la industria y pronóstico hasta 2028.
Análisis y perspectivas del mercado: mercado de biotecnología en Europa
Se espera que el mercado de la biotecnología gane crecimiento de mercado en el período de pronóstico de 2021 a 2028. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 27,9% en el período de pronóstico de 2021 a 2028 y se espera que alcance los USD 2.691.409,16 millones para 2028. La creciente prevalencia de enfermedades crónicas exige productos e instrumentos biotecnológicos avanzados que actúen como impulsores del crecimiento del mercado de la biotecnología.
La biotecnología es una tecnología que utiliza sistemas biológicos, organismos vivos o partes de estos para desarrollar o crear diferentes productos. La elaboración de cerveza y la elaboración de pan son ejemplos de procesos que caen dentro del concepto de biotecnología (uso de levadura (organismo vivo) para producir el producto deseado). Estos procesos tradicionales suelen utilizar los organismos vivos en su forma natural (o desarrollados mediante la cría), mientras que la forma más moderna de biotecnología generalmente implicará una modificación más avanzada del sistema biológico o del organismo. Hoy en día, la biotecnología cubre muchas disciplinas diferentes (por ejemplo, genética, bioquímica y biología molecular, entre otras). Cada año se desarrollan nuevas tecnologías y productos en las áreas de la medicina (desarrollo de nuevos medicamentos y terapias), la agricultura (desarrollo de plantas modificadas genéticamente, biocombustibles, tratamiento biológico) o la biotecnología industrial (producción de productos químicos, papel, textiles y alimentos).
El mercado de la biotecnología está creciendo debido a la mayor incidencia de enfermedades crónicas y al aumento de los avances tecnológicos. Además, el aumento de la cantidad de productos aprobados es otro factor que acelera el crecimiento del mercado de la biotecnología. Se espera que la falta de profesionales capacitados frene el crecimiento del mercado mundial de la biotecnología.
El informe del mercado de biotecnología proporciona detalles sobre la participación de mercado, los nuevos desarrollos y el análisis de la cartera de productos, el impacto de los actores del mercado nacional y localizado, analiza las oportunidades en términos de nuevos segmentos de ingresos, cambios en las regulaciones del mercado, aprobaciones de productos, decisiones estratégicas, lanzamientos de productos, expansiones geográficas e innovaciones tecnológicas en el mercado. Para comprender el análisis y el escenario del mercado de biotecnología, comuníquese con Data Bridge Market Research para obtener un informe de analista; nuestro equipo lo ayudará a crear una solución de impacto en los ingresos para lograr su objetivo deseado.
Alcance y tamaño del mercado de la biotecnología
El mercado de la biotecnología está segmentado en función del tipo de producto, la tecnología, la aplicación, el usuario final y el canal de distribución. El crecimiento entre segmentos le ayuda a analizar nichos de crecimiento y estrategias para abordar el mercado y determinar sus principales áreas de aplicación y la diferencia en sus mercados objetivo.
- Según el tipo de producto, el mercado de la biotecnología se segmenta en instrumentos, reactivos y servicios y software. En 2021, se espera que el segmento de instrumentos domine el mercado de la biotecnología debido a la disponibilidad de una amplia gama de soluciones innovadoras.
- En función de la tecnología, el mercado de la biotecnología se segmenta en nanobiotecnología, tecnología PCR, secuenciación de ADN, cromatografía, ingeniería y regeneración de tejidos, ensayos basados en células, fermentación y otros. En 2021, se espera que el segmento de la nanobiotecnología domine el mercado de la biotecnología debido a su amplia gama de aplicaciones.
- En función de la aplicación, el mercado de la biotecnología se segmenta en biofarmacia, bioindustria, bioservicios, bioinformática y bioagricultura. En 2021, se espera que el segmento de la biofarmacia domine el mercado de la biotecnología debido al creciente número de actividades de investigación y desarrollo.
- En función del usuario final, el mercado de la biotecnología se segmenta en empresas farmacéuticas y de biotecnología, organizaciones de investigación por contrato, institutos académicos y de investigación, entre otros. En 2021, se espera que el segmento de empresas farmacéuticas y de biotecnología domine el mercado de la biotecnología debido al aumento de las actividades de iniciativa de varias organizaciones de atención médica y organismos gubernamentales para fomentar los esfuerzos de investigación.
- Según el canal de distribución, el mercado de la biotecnología se segmenta en licitación directa, distribuidores externos y otros. En 2021, se espera que el segmento de licitación directa domine el mercado de la biotecnología debido a la creciente demanda de instrumentos biotecnológicos.
Análisis del mercado de biotecnología a nivel de país
Se analiza el mercado de la biotecnología y se proporciona información sobre el tamaño del mercado por país, tipo de producto, tecnología, aplicación, usuario final y canal de distribución como se menciona anteriormente.
Los países cubiertos en el informe del mercado de biotecnología son el Reino Unido, Alemania, Francia, España, Italia, Países Bajos, Suiza, Rusia, Turquía, Austria, Irlanda y el resto de Europa.
Alemania domina el mercado europeo gracias al aumento de la investigación y el desarrollo de productos biotecnológicos y software.
La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en la regulación en el mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Los puntos de datos como nuevas ventas, ventas de reemplazo, demografía del país, leyes regulatorias y aranceles de importación y exportación son algunos de los principales indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas globales y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los canales de venta se consideran al proporcionar un análisis de pronóstico de los datos del país.
Las crecientes actividades estratégicas de los principales actores del mercado para mejorar el conocimiento de la biotecnología están impulsando el crecimiento del mercado
El mercado de la biotecnología también le ofrece un análisis detallado del mercado para el crecimiento de cada país en un mercado en particular. Además, proporciona información detallada sobre la estrategia de los actores del mercado y su presencia geográfica. Los datos están disponibles para el período histórico de 2010 a 2019.
Análisis del panorama competitivo y la cuota de mercado de la biotecnología
El panorama competitivo del mercado de la biotecnología proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, los sitios e instalaciones de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, los procesos de prueba de productos, las aprobaciones de productos, las patentes, la amplitud y la extensión de los productos, el dominio de las aplicaciones y la curva de supervivencia de la tecnología. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de la empresa relacionado con el mercado de la biotecnología.
Las principales empresas que se dedican a la biotecnología son Trinity Biotech, Thermo Fisher Scientific Inc., Abbott, F. Hoffmann-La Roche Ltd, Charles River Laboratories, Eurofins Scientific, Promega Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Takara Bio Inc., Ortho Clinical Diagnostics, QIAGEN, Agilent Technologies, Inc., AstraZeneca, Merck KGaA, bioMérieux SA, Myriad Genetics, Inc., Illumina, Inc., Pacific Biosciences of California, Inc. y Biogen, entre otras empresas nacionales. Los analistas de DBMR comprenden las fortalezas competitivas y proporcionan un análisis competitivo para cada competidor por separado.
Numerosos contratos y acuerdos son también iniciados por empresas de todo el mundo, lo que también está acelerando el mercado de la biotecnología.
Por ejemplo,
- En febrero de 2021, Thermo Fisher Scientific Inc. anunció que había completado la adquisición previamente anunciada de Mesa Biotech, Inc. Se prevé que esta adquisición fortalezca el liderazgo de la empresa en el mercado de la biotecnología.
- En marzo de 2021, Charles River Laboratories anunció la adquisición de Retrogenix Limited, una organización de investigación por contrato (CRO) en etapa inicial que brinda servicios bioanalíticos especializados utilizando su tecnología patentada de microarrays celulares. Se prevé que esta adquisición fortalezca el sector comercial bioanalítico de la empresa.
La colaboración, el lanzamiento de productos, la expansión comercial, los premios y reconocimientos, las empresas conjuntas y otras estrategias de los actores del mercado están mejorando la presencia de la empresa en el mercado de la biotecnología, lo que también proporciona el beneficio para el crecimiento de las ganancias de la organización.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE BIOTECHNOLOGY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 EUROPE BIOTECHNOLOGY MARKET: REGULATIONS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING GERIATRIC POPULATION
5.1.2 GROWING PREVALENCE OF CHRONIC DISEASES
5.1.3 INCREASING TECHNOLOGICAL ADVANCEMENTS
5.1.4 WIDE RANGE OF APPLICATION
5.1.5 RISING FUNDING AND INVESTMENTS FOR THE DEVELOPMENT OF BIOTECHNOLOGY TECHNIQUES
5.2 RESTRAINTS
5.2.1 GROWING PACE OF PRODUCT RECALL
5.2.2 HIGH COST OF BIOTECHNOLOGY INSTRUMENT
5.2.3 STRICT REGULATORY FRAMEWORK
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY MAJOR MARKET PLAYERS
5.3.2 ESCALATION IN INNOVATION AND TECHNOLOGIES
5.3.3 RISING EXPENDITURE ON HEALTHCARE
5.4 CHALLENGES
5.4.1 SHORTAGE OF SKILLED PERSONNEL
5.4.2 LIMITATIONS OF DOWNSTREAM PURIFICATION
6 IMPACT OF COVID-19 ON THE EUROPE BIOTECHNOLOGY MARKET
6.1 IMPACT ON PRICE
6.2 IMPACT ON DEMAND
6.3 IMPACT ON SUPPLY CHAIN
6.4 STRATEGIC DECISIONS BY MANUFACTURERS
6.5 CONCLUSION
7 EUROPE BIOTECHNOLOGY MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 INSTRUMENT
7.3 REAGENTS
7.4 SERVICES & SOFTWARE
8 EUROPE BIOTECHNOLOGY MARKET, BY TECHNOLOGY
8.1 OVERVIEW
8.2 NANO BIOTECHNOLOGY
8.3 NANOCRYSTALS
8.4 NANOPARTICLES
8.5 LIPOSOMES
8.6 MICELLES
8.7 OTHERS
8.8 PCR TECHNOLOGY
8.9 CONVENTIONAL PCR
8.1 REAL-TIME PCR (QPCR)
8.11 DIGITAL PCR (DPCR)
8.12 REVERSE TRANSCRIPTION PCR (RT-PCR)
8.13 OTHER PCR
8.14 DNA SEQUENCING
8.15 SEQUENCING BY SYNTHESIS
8.16 ION SEMICONDUCTOR SEQUENCING
8.17 SEQUENCING BY LIGATION
8.18 PYROSEQUENCING
8.19 SINGLE MOLECULE REAL-TIME SEQUENCING
8.2 CHAIN TERMINATION SEQUENCING
8.21 NANOPORE SEQUENCING
8.22 CHROMATOGRAPHY
8.23 GAS CHROMATOGRAPHY
8.24 LIQUID CHROMATOGRAPHY
8.25 THIN LAYER CHROMATOGRAPHY
8.26 SUPERCRITICAL FLUID CHROMATOGRAPHY
8.27 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY/ULTRA HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC/UHPLC)
8.28 AFFINITY CHROMATOGRAPHY
8.29 TISSUE ENGINEERING AND REGENERATION
8.3 IMMUNOISOLATION TECHNOLOGY
8.31 CELL CULTURE TECHNOLOGY
8.32 STEM CELL TECHNOLOGY
8.33 CELL-BASED ASSAYS
8.34 FLOW CYTOMETRY
8.35 AUTOMATED HANDLING
8.36 LABEL-FREE-DETECTION
8.37 HIGH-THROUGHPUT SCREENING
8.38 OTHERS
8.39 FERMENTATION
8.4 UPSTREAM PROCESS
8.41 DOWNSTREAM PROCESS
8.42 OTHERS
9 EUROPE BIOTECHNOLOGY MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 BIOPHARMACY
9.3 BIOINDUSTRIAL
9.4 BIOSERVICES
9.5 BIOINFORMATICS
9.6 BIOAGRICULTURE
10 EUROPE BIOTECHNOLOGY MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3 CONTRACT RESEARCH ORGANIZATIONS
10.4 ACADEMIC & RESEARCH INSTITUTES
10.5 OTHERS
11 EUROPE BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 THIRD PARTY DISTRIBUTORS
11.4 OTHERS
12 EUROPE BIOTECHNOLOGY MARKET, BY REGION
12.1 EUROPE
12.1.1 GERMANY
12.1.2 FRANCE
12.1.3 U.K.
12.1.4 ITALY
12.1.5 SPAIN
12.1.6 BELGIUM
12.1.7 NETHERLANDS
12.1.8 RUSSIA
12.1.9 SWITZERLAND
12.1.10 TURKEY
12.1.11 AUSTRIA
12.1.12 NORWAY
12.1.13 HUNGARY
12.1.14 LITHUANIA
12.1.15 IRELAND
12.1.16 POLAND
12.1.17 REST OF EUROPE
13 EUROPE BIOTECHNOLOGY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 THERMO FISHER SCIENTIFIC INC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 F. HOFFMANN-LA ROCHE LTD
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 ASTRAZENECA
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 MERCK KGAA
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 ABBOTT
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.6 AGILENT TECHNOLOGIES, INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 BIOGEN
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 BIOMÉRIEUX SA
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENTS
15.9 BIO-RAD LABORATORIES, INC.
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENTS
15.1 CHARLES RIVER LABORATORIES
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 EUROFINS SCIENTIFIC
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 ILLUMINA, INC.
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT
15.13 MYRIAD GENETICS, INC.
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENTS
15.14 ORTHO CLINICAL DIAGNOSTICS.
15.14.1 COMPANY SNAPSHOT
15.14.2 REVENUE ANALYSIS
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENTS
15.15 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENTS
15.16 PERKINELMER INC.
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENTS
15.17 PROMEGA CORPORATION
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.18 TAKARA BIO INC.
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENTS
15.19 TRINITY BIOTECH
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENTS
15.2 QIAGEN
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
Lista de Tablas
TABLE 1 EUROPE CANCER INCIDENCE IN BOTH THE GENDERS (2018)
TABLE 2 EUROPE CANCER INCIDENCE IN MEN (2018)
TABLE 3 EUROPE CANCER INCIDENCE IN WOMEN (2018)
TABLE 4 EUROPE BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 5 EUROPE INSTRUMENTS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 EUROPE REAGENTS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 EUROPE SERVICES & SOFTWARE IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 EUROPE BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 9 EUROPE NANO BIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 EUROPE NANO BIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 11 EUROPE PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 EUROPE PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 13 EUROPE DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 EUROPE DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 15 EUROPE CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 EUROPE CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 17 EUROPE TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 EUROPE TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 19 EUROPE CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 EUROPE CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 21 EUROPE FERMENTATION IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 EUROPE FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 23 EUROPE OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 EUROPE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 25 EUROPE BIOPHARMACY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 EUROPE BIOINDUSTRIAL IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 EUROPE BIOSERVICES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 EUROPE BIOINFORMATICS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 EUROPE BIOAGRICULTURE IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 EUROPE BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 31 EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 EUROPE CONTRACT RESEARCH ORGANIZATIONS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 EUROPE ACADEMIC & RESEARCH INSTITUTES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 EUROPE OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 EUROPE BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 36 EUROPE DIRECT TENDER IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 EUROPE THIRD PARTY DISTRIBUTORS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 EUROPE OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 EUROPE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 40 EUROPE BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 41 EUROPE BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 42 EUROPE FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 43 EUROPE TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 44 EUROPE PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 45 EUROPE NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 46 EUROPE CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 47 EUROPE DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 48 EUROPE CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 49 EUROPE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 50 EUROPE BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 EUROPE BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 52 GERMANY BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 53 GERMANY BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 54 GERMANY FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 55 GERMANY TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 56 GERMANY PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 57 GERMANY NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 58 GERMANY CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 59 GERMANY DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 60 GERMANY CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 61 GERMANY BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 62 GERMANY BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 63 GERMANY BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 64 FRANCE BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 65 FRANCE BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 66 FRANCE FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 67 FRANCE TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 68 FRANCE PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 69 FRANCE NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 70 FRANCE CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 71 FRANCE DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 72 FRANCE CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 73 FRANCE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 74 FRANCE BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 75 FRANCE BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 76 U.K. BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 77 U.K. BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 78 U.K. FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 79 U.K. TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 80 U.K. PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 81 U.K. NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 82 U.K. CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 83 U.K. DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 84 U.K. CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 85 U.K. BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 86 U.K. BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 87 U.K. BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 88 ITALY BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 89 ITALY BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 90 ITALY FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 91 ITALY TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 92 ITALY PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 93 ITALY NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 94 ITALY CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 95 ITALY DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 96 ITALY CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 97 ITALY BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 98 ITALY BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 99 ITALY BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 100 SPAIN BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 101 SPAIN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 102 SPAIN FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 103 SPAIN TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 104 SPAIN PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 105 SPAIN NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 106 SPAIN CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 107 SPAIN DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 108 SPAIN CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 109 SPAIN BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 110 SPAIN BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 111 SPAIN BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 112 BELGIUM BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 113 BELGIUM BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 114 BELGIUM FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 115 BELGIUM TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 116 BELGIUM PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 117 BELGIUM NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 118 BELGIUM CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 119 BELGIUM DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 120 BELGIUM CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 121 BELGIUM BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 122 BELGIUM BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 123 BELGIUM BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 124 NETHERLANDS BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 125 NETHERLANDS BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 126 NETHERLANDS FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 127 NETHERLANDS TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 128 NETHERLANDS PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 129 NETHERLANDS NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 130 NETHERLANDS CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 131 NETHERLANDS DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 132 NETHERLANDS CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 133 NETHERLANDS BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 134 NETHERLANDS BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 135 NETHERLANDS BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 136 RUSSIA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 137 RUSSIA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 138 RUSSIA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 139 RUSSIA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 140 RUSSIA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 141 RUSSIA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 142 RUSSIA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 143 RUSSIA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 144 RUSSIA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 145 RUSSIA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 146 RUSSIA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 147 RUSSIA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 148 SWITZERLAND BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 149 SWITZERLAND BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 150 SWITZERLAND FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 151 SWITZERLAND TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 152 SWITZERLAND PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 153 SWITZERLAND NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 154 SWITZERLAND CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 155 SWITZERLAND DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 156 SWITZERLAND CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 157 SWITZERLAND BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 158 SWITZERLAND BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 159 SWITZERLAND BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 160 TURKEY BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 161 TURKEY BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 162 TURKEY FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 163 TURKEY TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 164 TURKEY PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 165 TURKEY NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 166 TURKEY CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 167 TURKEY DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 168 TURKEY CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 169 TURKEY BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 170 TURKEY BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 171 TURKEY BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 172 AUSTRIA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 173 AUSTRIA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 174 AUSTRIA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 175 AUSTRIA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 176 AUSTRIA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 177 AUSTRIA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 178 AUSTRIA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 179 AUSTRIA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 180 AUSTRIA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 181 AUSTRIA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 182 AUSTRIA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 183 AUSTRIA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 184 NORWAY BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 185 NORWAY BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 186 NORWAY FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 187 NORWAY TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 188 NORWAY PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 189 NORWAY NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 190 NORWAY CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 191 NORWAY DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 192 NORWAY CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 193 NORWAY BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 194 NORWAY BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 195 NORWAY BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 196 HUNGARY BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 197 HUNGARY BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 198 HUNGARY FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 199 HUNGARY TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 200 HUNGARY PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 201 HUNGARY NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 202 HUNGARY CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 203 HUNGARY DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 204 HUNGARY CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 205 HUNGARY BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 206 HUNGARY BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 207 HUNGARY BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 208 LITHUANIA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 209 LITHUANIA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 210 LITHUANIA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 211 LITHUANIA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 212 LITHUANIA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 213 LITHUANIA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 214 LITHUANIA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 215 LITHUANIA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 216 LITHUANIA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 217 LITHUANIA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 218 LITHUANIA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 219 LITHUANIA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 220 IRELAND BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 221 IRELAND BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 222 IRELAND FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 223 IRELAND TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 224 IRELAND PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 225 IRELAND NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 226 IRELAND CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 227 IRELAND DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 228 IRELAND CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 229 IRELAND BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 230 IRELAND BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 231 IRELAND BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 232 POLAND BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 233 POLAND BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 234 POLAND FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 235 POLAND TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 236 POLAND PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 237 POLAND NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 238 POLAND CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 239 POLAND DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 240 POLAND CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 241 POLAND BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 242 POLAND BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 243 POLAND BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 244 REST OF EUROPE BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
Lista de figuras
FIGURE 1 EUROPE BIOTECHNOLOGY MARKET: SEGMENTATION
FIGURE 2 EUROPE BIOTECHNOLOGY MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE BIOTECHNOLOGY MARKET: DROC ANALYSIS
FIGURE 4 EUROPE BIOTECHNOLOGY MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE BIOTECHNOLOGY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE BIOTECHNOLOGY MARKET: MULTIVARIATE MODELLING
FIGURE 7 EUROPE BIOTECHNOLOGY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE BIOTECHNOLOGY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE BIOTECHNOLOGY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE BIOTECHNOLOGY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 EUROPE BIOTECHNOLOGY MARKET: SEGMENTATION
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE EUROPE BIOTECHNOLOGY MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 GROWING PREVALENCE OF CHRONIC DISEASES IS DRIVING THE EUROPE BIOTECHNOLOGY MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 INSTRUMENTS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE BIOTECHNOLOGY MARKET IN 2021 & 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE BIOTECHNOLOGY MARKET
FIGURE 16 CANCER DEATH RATES BY AGE GROUP (2017)
FIGURE 17 NUMBER OF NEW CANCER CASES FOR ALL AGE GROUPS (IN 2018)
FIGURE 18 NUMBER OF NEW CASES IN MALES FOR ALL AGE GROUPS (IN 2018)
FIGURE 19 NUMBER OF NEW CASES IN FEMALES FOR ALL AGE GROUPS (IN 2018)
FIGURE 20 EUROPE BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, 2020
FIGURE 21 EUROPE BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, 2021-2028 (USD MILLION)
FIGURE 22 EUROPE BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 23 EUROPE BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 24 EUROPE BIOTECHNOLOGY MARKET : BY TECHNOLOGY, 2020
FIGURE 25 EUROPE BIOTECHNOLOGY MARKET : BY TECHNOLOGY, 2021-2028 (USD MILLION)
FIGURE 26 EUROPE BIOTECHNOLOGY MARKET : BY TECHNOLOGY, CAGR (2021-2028)
FIGURE 27 EUROPE BIOTECHNOLOGY MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 28 EUROPE BIOTECHNOLOGY MARKET : BY APPLICATION, 2020
FIGURE 29 EUROPE BIOTECHNOLOGY MARKET : BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 30 EUROPE BIOTECHNOLOGY MARKET : BY APPLICATION, CAGR (2021-2028)
FIGURE 31 EUROPE BIOTECHNOLOGY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 32 EUROPE BIOTECHNOLOGY MARKET: BY END USER, 2020
FIGURE 33 EUROPE BIOTECHNOLOGY MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 34 EUROPE BIOTECHNOLOGY MARKET: BY END USER, CAGR (2021-2028)
FIGURE 35 EUROPE BIOTECHNOLOGY MARKET: BY END USER, LIFELINE CURVE
FIGURE 36 EUROPE BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 37 EUROPE BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 38 EUROPE BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 39 EUROPE BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 40 EUROPE BIOTECHNOLOGY MARKET: SNAPSHOT (2020)
FIGURE 41 EUROPE BIOTECHNOLOGY MARKET: BY COUNTRY (2020)
FIGURE 42 EUROPE BIOTECHNOLOGY MARKET: BY COUNTRY (2021 & 2028)
FIGURE 43 EUROPE BIOTECHNOLOGY MARKET: BY COUNTRY (2020 & 2028)
FIGURE 44 EUROPE BIOTECHNOLOGY MARKET: BY PRODUCT TYPE (2021-2028)
FIGURE 45 EUROPE BIOTECHNOLOGY MARKET: COMPANY SHARE 2020 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
